PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
-7.40%
Negative ROE indicates either losses or negative equity – a major Benjamin Graham warning. Confirm if leverage or poor profitability is the cause.
-6.83%
Negative ROA indicates net losses or excessive assets. Benjamin Graham would question viability or capital misallocation.
-7.50%
Negative ROCE suggests negative EBIT or an inflated capital base. Benjamin Graham would check if the firm is structurally unprofitable.
85.43%
Gross margin above 50% – Exceptional. Benjamin Graham would verify if cost advantages or brand power drive this.
-549.36%
Negative operating margin means operating expenses exceed gross profit – a classic Benjamin Graham red flag. Investigate cost structure or revenue viability.
-541.91%
Negative net margin indicates net losses. Benjamin Graham would caution about solvency and capital reserves.